相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Orexins and Gastrointestinal Functions
M. C. Baccari
CURRENT PROTEIN & PEPTIDE SCIENCE (2010)
Orexin receptor antagonists: a review of promising compounds patented since 2006
Paul J. Coleman et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Ligand Regulation of the Quaternary Organization of Cell Surface M3 Muscarinic Acetylcholine Receptors Analyzed by Fluorescence Resonance Energy Transfer (FRET) Imaging and Homogeneous Time-resolved FRET
Elisa Alvarez-Curto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
High content screening: seeing is believing
Fabian Zanella et al.
TRENDS IN BIOTECHNOLOGY (2010)
Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX2 receptor
P. Malherbe et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
The Hypocretins and their Role in Narcolepsy
Daniel Kroeger et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Signal Transduction via Cannabinoid Receptors
George D. Dalton et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
The Current Status and Future Perspectives of Studies of Cannabinoid Receptor 1 Antagonists as Anti-Obesity Agents
Hyeon-Kyu Lee et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Emerging drugs for insomnia: new frontiers for old and novel targets
Shannon S. Sullivan et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
Rimonabant for the treatment of overweight and obese people
J. Burch et al.
HEALTH TECHNOLOGY ASSESSMENT (2009)
The Action and Mode of Binding of Thiazolidinedione Ligands at Free Fatty Acid Receptor 1
Nicola J. Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Biochemical and Electrophysiological Characterization of Almorexant, a Dual Orexin 1 Receptor (OX1)/Orexin 2 Receptor (OX2) Antagonist: Comparison with Selective OX1 and OX2 Antagonists
Pari Malherbe et al.
MOLECULAR PHARMACOLOGY (2009)
CXCR2 Inverse Agonism Detected by Arrestin Redistribution
Simone Kredel et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Cannabinoids and appetite: Food craving and food pleasure
Tim C. Kirkham
INTERNATIONAL REVIEW OF PSYCHIATRY (2009)
A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization
G. Milligan
BRITISH JOURNAL OF PHARMACOLOGY (2008)
An engineered protein tag for multiprotein labeling in living cells
Arnaud Gautier et al.
CHEMISTRY & BIOLOGY (2008)
Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed mu opioid receptors
Meritxell Canals et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors
Dai-Fei Wu et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Morphine Desensitization, Internalization, and Down-Regulation of the μ Opioid Receptor Is Facilitated by Serotonin 5-Hydroxytryptamine2A Receptor Coactivation
Juan F. Lopez-Gimenez et al.
MOLECULAR PHARMACOLOGY (2008)
Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization
Damien Maurel et al.
NATURE METHODS (2008)
Regulation of OX1 orexin/hypocretin receptor-coupling to phospholipase C by Ca2+ influx
L. Johansson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
G protein-coupled receptor dimerisation: Molecular basis and relevance to function
Graeme Milligan
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function
James Ellis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Evaluation of two novel tag-based labelling technologies for site-specific modification of proteins
Aline Tirat et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2006)
OX1 orexin receptors activate extracellular signal-regulated kinase in Chinese hamster ovary cells via multiple mechanisms: The role of Ca2+ influx in OX1 receptor signaling
S Ammoun et al.
MOLECULAR ENDOCRINOLOGY (2006)
The sustainability of interactions between the orexin-1 receptor and β-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation
S Milasta et al.
BIOCHEMICAL JOURNAL (2005)
Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology
T Sakurai
REGULATORY PEPTIDES (2005)
Characterisation of the binding of [H-3]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor
CJ Langmead et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
CypHer 5: A generic approach for measuring the activation and trafficking of G protein-coupled receptors in live cells
EJ Adie et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2003)
Orexins and their receptors: structural aspects and role in peripheral tissues
T Voisin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Cannabinoid receptors and their ligands
RG Pertwee et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Visualizing differences in ligand-induced β-arrestin-GFP interactions and trafficking between three recently characterized G protein-coupled receptors
NA Evans et al.
JOURNAL OF NEUROCHEMISTRY (2001)
SB-334867-A: the first selective orexin-1 receptor antagonist
D Smart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
分享论文
